Autologous hematopoietic stem cell transplantation for very active relapsing-remitting multiple sclerosis: report of two cases-Reference-Cited by-同舟云学术

Autologous hematopoietic stem cell transplantation for very active relapsing-remitting multiple sclerosis: report of two cases

Published:2007-02-16 Issue:5 Volume:13 Page:676-678
ISSN:1352-4585
Container-title:Multiple Sclerosis Journal
language:en
Short-container-title:Mult Scler

Author:

Portaccio E.¹,Amato M.P.²,Siracusa G.²,Pagliai F.³,Sorbi S.²,Guidi S.³,Bosi A.³,Saccardi R.³

Affiliation:

1. Department of Neurology, University of Florence, Florence, Italy,

2. Department of Neurology, University of Florence, Florence, Italy

3. Bone Marrow Transplantation Unit, Careggi Hospital, Florence, Italy

Abstract

Autologous hematopoietic stem cell transplantation (AHSCT) has been proposed as a rescue treatment in multiple sclerosis (MS) patients not responding to first- or second-line therapies. To date, most of the treated cases had a secondary progressive disease course. However, patients with high inflammatory activity, but no secondary progression of the disease, could be candidates to take greater advantage of AHSCT. In this paper, we report two cases with very active, relapsing-remitting (RR) MS, who underwent AHSCT, and obtained a dramatic resolution to disease activity. Multiple Sclerosis 2007; 13: 676-678. http://msj.sagepub.com

Publisher

SAGE Publications

Subject

Neurology (clinical),Neurology

Link

http://journals.sagepub.com/doi/pdf/10.1177/1352458506073502

Reference9 articles.

1. Autologous haematopoietic-stem-cell transplantation for multiple sclerosis

2. Autologous hemopoietic stem cell transplantation in the treatment of multiple sclerosis: rationale and clinical experience

3. Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS

4. Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients

5. Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical neurorestorative cell therapies: Developmental process, current state and future prospective;Journal of Neurorestoratology;2020

2. Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis;Nature Reviews Neurology;2017-06-16

3. Cell Therapy for Multiple Sclerosis;CNS Drugs;2017-04-10

4. Clinical Application of Autologous Adipose Stem Cells in Patients with Multiple Sclerosis: Preliminary Results;Mediators of Inflammation;2016

5. Autologous hematopoietic stem cell transplantation in multiple sclerosis: A phase II trial;Neurology;2015-02-11